Rentokil Initial plc (LON:RTO - Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 353.35 ($4.75) and traded as high as GBX 369.10 ($4.96). Rentokil Initial shares last traded at GBX 366.60 ($4.92), with a volume of 4,793,226 shares changing hands.
Wall Street Analyst Weigh In
Several research firms recently commented on RTO. Deutsche Bank Aktiengesellschaft raised their target price on Rentokil Initial from GBX 425 to GBX 435 and gave the company a "buy" rating in a research report on Monday, July 21st. JPMorgan Chase & Co. reiterated a "no recommendation" rating on shares of Rentokil Initial in a research report on Monday, August 11th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a GBX 440 price target on shares of Rentokil Initial in a research report on Friday, August 1st. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Rentokil Initial has an average rating of "Buy" and an average target price of GBX 435.
View Our Latest Analysis on RTO
Rentokil Initial Trading Up 1.1%
The company has a debt-to-equity ratio of 113.35, a quick ratio of 1.76 and a current ratio of 1.04. The firm has a market capitalization of £9.32 billion, a P/E ratio of 2,887.07, a price-to-earnings-growth ratio of 0.56 and a beta of 0.55. The firm has a 50 day moving average price of GBX 366.03 and a two-hundred day moving average price of GBX 353.35.
Rentokil Initial Company Profile
(
Get Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.